XYL — Xylem Inc.

As of 2026-08-27 the tape is bearish: price is 10.2% below the 200-day MA, RSI is 39.1, and the stock sits below both the 20-day and 50-day MAs. The negative mood is driven by top-line deceleration and a slight FY26 revenue guidance cut, even though Q2 adjusted EPS of $1.46 beat and the FY adjusted EPS guide was raised to $5.55-$5.70.

Revenue trend is structurally positive but decelerating: FY2025 sales rose about 5.5% to $9.04B, yet YoY growth slowed from 7.9% in Q3 2025 and 6.3% in Q4 2025 to 2.7% in Q1 2026 and 1.5% in Q2 2026. That is a clear slowdown, not a one-quarter blip. Offsetting it, operating margin jumped from 13.3% in Q2 2025 to 16.7% in Q2 2026 and reported EPS rose from $0.93 to $1.11; Q2 order intake reportedly surged 42% to $3.1B and backlog is over $5B, suggesting the revenue trough may be bottoming into 2H26/2027.

At 2026-08-27, the stock is cheap relative to its own history. Trailing P/E is 26.8x on reported EPS of $4.275, which includes charges, but on FY26E adjusted EPS of about $5.664 the forward P/E is only ~19.9x. P/S is 2.88x versus the 5-year average of 3.62x, and the 5-year average P/E of 42.7x is far above the current multiple. PEG of 3.05 based on trailing figures overstates cost; with forward EPS growth in the high single digits to low teens, valuation is fair-to-cheap, not expensive.

The price is discounting stagnant revenue, not the improving margin/backlog story. At roughly 19.9x forward adjusted EPS, the market is paying a trough-type multiple for a business with >$5B backlog and expanding margins. If management delivers near the $5.66 midpoint and the multiple merely returns to about 24x, fair value is roughly $136-$139; if order conversion restores 5-7% revenue growth, estimates could move higher. Conversely, if municipal/industrial demand softens and FY26 revenue misses, the low multiple is justified.

As of 2026-08-27, RSI(14) was 39.13 - bearish momentum but not yet oversold. Price was 4.35% below the 20-day, 4.54% below the 50-day, and 10.18% below the 200-day, so the structure is a downtrend, not a stable range. First support is the 52-week low near $105.29; resistance is the 50-day near $117.96 and the 200-day near $119.86. Entry timing favors waiting for stabilization or an RSI turn rather than buying into a falling 200-day MA.

• Higher Treasury yields and bond-market volatility are compressing multiples for industrial and infrastructure-linked equities, a major headwind for XYL's valuation.
• Mandated U.S./U.K. municipal water-infrastructure spending is a secular tailwind that underpins multi-year backlog and pricing power.
• Broader industrial sector rotation has hit cyclical machinery names despite relatively stable end-markets, creating a valuation gap.
• Regulatory compliance cycles are normalizing, causing order-intake swings and near-term revenue volatility.
• Portfolio reshaping via acquisitions of Cornell and Roper Pumps and the divestiture of the international metering business changes mix toward higher-growth industrial niche markets.

• Q3 2026 earnings around October 27, 2026 - the key test of whether $9.2B revenue guidance holds and margin expansion continues.
• CFO transition on September 1, 2026; Andrea van der Berg takes over, so financial execution and tone on the sell-side will be watched.
• Conversion of the $3.1B Q2 order intake and >$5B backlog into reported revenue.
• Integration of Cornell Pump and Roper Pump acquisitions and completion of the international metering divestiture.
• Ongoing buyback activity ($1.24B in H1 2026) and dividend growth supporting returns even if the stock stays range-bound.

• Revenue deceleration is real: Q2 growth of only 1.5% and a trimmed FY revenue guide could extend if order conversion slows or municipal budget cycles pause.
• Elevated interest rates could keep the stock below its moving averages and cap multiple expansion even with good fundamentals.
• CFO transition and two recent acquisitions create execution and integration risk.
• If FY26 adjusted EPS guidance is cut, the ~19.9x forward multiple would look less cheap and analyst targets would reset lower.

XYL is a high-quality water-infrastructure franchise with durable secular tailwinds, expanding margins, and an attractive ~20x forward adjusted multiple as of 2026-08-27. But near-term revenue momentum is weak and the technical chart is in a downtrend, so the risk/reward is balanced rather than compelling; this is a watch-list buy, not a chase, and not personalized investment advice.

I calculated $138.77 by applying a 24.5x forward P/E to FY2026E adjusted EPS of $5.664 - a material discount to XYL's 5-year average P/E of 42.7x and a premium to the current ~19.9x forward multiple, reflecting improving margins and a >$5B backlog while keeping conservatism on the slowing top line.